NR1H4 and primary biliary cholangitis: The improvement in pruritus with seladelpar contrasts with obeticholic acid, a bile acid analog and FXR agonist that is conditionally approved as a second-line treatment for PBC, which can induce or worsen pruritus in a dose-dependent manner.15,32,33